It is essential that both primary and secondary bodies be selected to be in line with the needs of the intended application so that the application itself can provide the answers and to the researcher’s questions.
The table below shows an easy-to-use, three-step guide from Abcam that highlights the strengths and limitations of a range of applications. It prompts the user to consider primary antibodies, the importance of validation, and the range of secondary antibodies available.
Abcam is a global life sciences company providing highly validated antibodies and other binders and assays to the research and clinical communities to help advance the understanding of biology and causes of disease.
Abcam’s mission is to serve life scientists to help them achieve their mission faster by listening to their needs, continuously innovating and improving and by giving them the tools, data and experience they want. Abcam’s ambition is to become the most influential life science company for researchers worldwide.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.